Brief: Coherus BioSciences Q4 EPS USD -0.71
13/03/2024 20:01
Mar 13 (Reuters) - Coherus BioSciences Q4 pretax profit USD -79.653 million. * Q4 operating income USD -68.905 million * Q4 adjusted net income USD -68.918 million * Q4 net income USD -79.653 million * Q4 sales USD 91.524 million vs. IBES estimate USD 96.4 million
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million